|
|
Office Locations:
|
319 N. 3rd Street, Suite 301
Wilmington, NC 28401
Phone: 910-558-6885
| | |
|
|
|
- Early
- Growth
- Middle Market
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Eshelman Ventures is an investment company primarily interested in healthcare companies. The firm was founded by Fred Eshelman, who previously founded and served as CEO and Executive Chairman of Pharmaceutical Product Development (PPDI, NASDAQ) prior to the sale of the company to private equity interests. Although Eshelman Ventures concentrates in healthcare, the firm will consider other themes that are attractive and have large potential markets. On December 3, 2014 Dr. Fred Eshelman committed $100 million to the UNC Eshelman School of Pharmacy.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
